HIGHLIGHTS
- who: Posted Date May and colleagues from the Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin`s Clinical Research Center for have published the research work: Safety and Eufffdcacy of Immune Checkpoint Inhibitors in Advanced Cancer patients with Autoimmune Disease: a Meta-Analysis, in the Journal: (JOURNAL)
- what: The authors aim to assess the rate of irAEs, PFS, and OS of patients on ICI therapy.
- how: The following information was collected independently the first author`s name publication time country and patient characteristics such as number of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.